Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo.
Safavi S, Järnum S, Vannas C, Udhane S, Jonasson E, Tomic TT, Grundevik P, Fagman H, Hansson M, Kalender Z, Jauhiainen A, Dolatabadi S, Stratford EW, Myklebost O, Eriksson M, Stenman G, Schneider-Stock R, Ståhlberg A, Åman P. Safavi S, et al. Among authors: fagman h. Oncotarget. 2016 Jan 5;7(1):433-45. doi: 10.18632/oncotarget.6336. Oncotarget. 2016. PMID: 26595521 Free PMC article.
PRDM10-rearranged Soft Tissue Tumor: A Clinicopathologic Study of 9 Cases.
Puls F, Pillay N, Fagman H, Palin-Masreliez A, Amary F, Hansson M, Kindblom LG, McCulloch TA, Meligonis G, Muc R, Rissler P, Sumathi VP, Tirabosco R, Hofvander J, Magnusson L, Nilsson J, Flanagan AM, Mertens F. Puls F, et al. Among authors: fagman h. Am J Surg Pathol. 2019 Apr;43(4):504-513. doi: 10.1097/PAS.0000000000001207. Am J Surg Pathol. 2019. PMID: 30570551
Response to BRAF/MEK Inhibition in A598_T599insV BRAF Mutated Melanoma.
Bjursten S, Vannas C, Filges S, Puls F, Pandita A, Fagman H, Ståhlberg A, Levin M. Bjursten S, et al. Among authors: fagman h. Case Rep Oncol. 2019 Nov 21;12(3):872-879. doi: 10.1159/000504291. eCollection 2019 Sep-Dec. Case Rep Oncol. 2019. PMID: 31824282 Free PMC article.
Overlapping morphological, immunohistochemical and genetic features of superficial CD34-positive fibroblastic tumor and PRDM10-rearranged soft tissue tumor.
Puls F, Carter JM, Pillay N, McCulloch TA, Sumathi VP, Rissler P, Fagman H, Hansson M, Amary F, Tirabosco R, Magnusson L, Nilsson J, Flanagan AM, Folpe AL, Mertens F. Puls F, et al. Among authors: fagman h. Mod Pathol. 2022 Jun;35(6):767-776. doi: 10.1038/s41379-021-00991-8. Epub 2021 Dec 30. Mod Pathol. 2022. PMID: 34969957 Free article.
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
Wadensten E, Wessman S, Abel F, Diaz De Ståhl T, Tesi B, Orsmark Pietras C, Arvidsson L, Taylan F, Fransson S, Vogt H, Poluha A, Pradhananga S, Hellberg M, Lagerstedt-Robinson K, Raj Somarajan P, Samuelsson S, Orrsjö S, Maqbool K, Henning K, Strid T, Ek T, Fagman H, Olsson Bontell T, Martinsson T, Puls F, Kogner P, Wirta V, Pronk CJ, Wille J, Rosenquist R, Nistér M, Mertens F, Sabel M, Norén-Nyström U, Grillner P, Nordgren A, Ljungman G, Sandgren J, Gisselsson D; Genomic Medicine Sweden Childhood Cancer Working Group. Wadensten E, et al. Among authors: fagman h. JCO Precis Oncol. 2023 Jun;7:e2300039. doi: 10.1200/PO.23.00039. JCO Precis Oncol. 2023. PMID: 37384868 Free PMC article.
Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature.
Maya-González C, Delgado-Vega AM, Taylan F, Lagerstedt Robinson K, Hansson L, Pal N, Fagman H, Puls F, Wessman S, Stenman J, Georgantzi K, Fransson S, Díaz De Ståhl T, Ek T, Palmer R, Tesi B, Kogner P, Martinsson T, Nordgren A. Maya-González C, et al. Among authors: fagman h. Am J Med Genet A. 2024 Dec;194(12):e63812. doi: 10.1002/ajmg.a.63812. Epub 2024 Jul 11. Am J Med Genet A. 2024. PMID: 38990105 Review.
Discovery of a rare GKAP1-NTRK2 fusion in a pediatric low-grade glioma, leading to targeted treatment with TRK-inhibitor larotrectinib.
Deland L, Keane S, Olsson Bontell T, Sjögren H, Fagman H, Øra I, De La Cuesta E, Tisell M, Nilsson JA, Ejeskär K, Sabel M, Abel F. Deland L, et al. Among authors: fagman h. Cancer Biol Ther. 2021 Mar 4;22(3):184-195. doi: 10.1080/15384047.2021.1899573. Epub 2021 Apr 5. Cancer Biol Ther. 2021. PMID: 33820494 Free PMC article.
55 results